Skip to content
Menu
Home
About us
Who we are
Leadership
Funding
Lead Compound: SNF472
Mechanism of action
Indications
News & Events
News
Events
Careers
Compassionate use
Contact
Close Menu
OVERVIEW
Therapeutic / RX Pipeline
OTC Products / Pipeline
Latest News
04/30/2015
Sanifit starts Phase Ib/II with SNF472 in dialysis patients
02/04/2015
Sanifit receives FDA IND approval
«
‹
11
12
13
14
